ATF4 and breast cancer: Additionally, breast cancer cells in the hypoxic TME upregulate the expression of activating transcription factor 4 (ATF4), a member of the ATF/cAMP response element‐binding protein (CREB) family, which has been reported to be related to the recruitment of macrophages and promotion of angiogenesis which indirectly support tumor growth.23